Tanuja Chitnis

The impact of the gut microbiota on clinical features in progressive MS 1:13
The impact of the gut microbiota on clinical features in progressive MS
Tanuja Chitnis • 26 Apr 2021
Severe COVID-19 in pediatric MS patients 1:11
Severe COVID-19 in pediatric MS patients
Tanuja Chitnis • 26 Apr 2021
Neurofilament light chain as a biomarker in pediatric MS 0:53
Neurofilament light chain as a biomarker in pediatric MS
Tanuja Chitnis • 26 Apr 2021
Managing pediatric MS in the current era 1:46
Managing pediatric MS in the current era
Tanuja Chitnis • 26 Apr 2021
Determining the optimal treatment strategy in MS 4:18
Determining the optimal treatment strategy in MS
Tanuja Chitnis • 23 Feb 2021
Changing approaches to cognitive assessment in MS 1:38
Changing approaches to cognitive assessment in MS
Tanuja Chitnis • 23 Feb 2021
Ensemble learning methods predict disease course in MS 2:26
Ensemble learning methods predict disease course in MS
Tanuja Chitnis • 23 Feb 2021
Serum neurofilament levels are associated with health outcomes and resource use in MS 1:34
Serum neurofilament levels are associated with health outcomes and resource use in MS
Tanuja Chitnis • 23 Feb 2021
MS disease stage modulates the relationship between serum neurofilament light and age 1:45
MS disease stage modulates the relationship between serum neurofilament light and age
Tanuja Chitnis • 23 Feb 2021
Emerging research in pediatric MS 1:26
Emerging research in pediatric MS
Tanuja Chitnis • 24 May 2020
Pediatric MS: where does research need to move? 1:08
Pediatric MS: where does research need to move?
Tanuja Chitnis • 24 May 2020
Pediatric versus adult multiple sclerosis 1:24
Pediatric versus adult multiple sclerosis
Tanuja Chitnis • 24 May 2020
TERIKIDS study: teriflunomide in pediatric patients with relapsing MS 2:12
TERIKIDS study: teriflunomide in pediatric patients with relapsing MS
Tanuja Chitnis • 24 May 2020
The content of VJNeurology is intended for healthcare professionals